01.03.2023 Pasi Kankaanpää starts as the CEO of Biomendex on the first of March 2023 11.06.2021 Adaptos® clinical study started with Hospital Orton, Oral and Planmeca 03.05.2021 Biomendex closed 1 M€ investment round 01.09.2020 Biomendex held bone regeneration -seminar 08.04.2020 More functional synthetic bone graft substitutes are developed with reliable porosity analysis and properly chosen analysis methods